Predicting time to medication access for hematologic malignancies: the impact of an integrated specialty pharmacy and limited distribution drug networks

Background: Barriers to accessing oral oncolytic therapy include insurance authorization, high copays and limited distribution drug (LDD) networks. In September 2015, a pharmacist joined an outpatient hematology clinic to facilitate timeliness of medications (for which the pharmacy has access) dispe...

Descripción completa

Detalles Bibliográficos
Autores principales: Zuckerman, Autumn D., Peter, Megan E., Starks, Samuel, Maulis, Matthew, Declerq, Josh, Choi, Leena, Jagasia, Madan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Poster #45
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764336/
http://dx.doi.org/10.1080/21556660.2019.1658326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764336/
http://dx.doi.org/10.1080/21556660.2019.1658326

Ejemplares similares